Export-oriented businesses like pharma, CRAM and the specialty chemicals will have exceedingly good growth even in FY21. But in FY22 and FY23, we expect a lot of these businesses to have very nice EBITDA and bottom line growth, says Sachin Shah, Fund (Portfolio) manager, Emkay Investment Managers. Some of the top stocks in your portfolio … Read more
NEW DELHI: Benchmark indices registered gains of one-and-a-half per cent during a week that saw tech stocks in the US plunging sharply but spectacular performance by Reliance Industries kept the market buoyant. Among the outperformers of this week, most names belonged to the internet, pharma and technology sectors while PSU sectors and multiplexes were among … Read more
NEW DELHI: The domestic equity market has turned listless over the past couple of weeks following an exuberant rally from the March lows. The one-step-forward-and-two-step-back kind of movement might frustrate investors, but it’s a reminder that there is no shortcut to making money. Patience! That’s the broader sense one gets in some of the tweets … Read more
NEW DELHI: Future Group firm Future Consumer Ltd (FCL) on Monday said it has defaulted on payment of principal redemption and interest on non-convertible debentures. The current default amount includes principal of Rs 20 crore and interest of Rs 2.03 crore, payable annually, it said. In a regulatory filing, the company said it has been … Read more
NEW DELHI: Kishore Biyani, popularly known as KB among colleagues and considered as the pioneer of modern retail in India taking convenience shopping to the masses, is finally bowing to the winds of change blowing across the sector, giving the control of what he nurtured for over three decades to Reliance Retail. Biyani (59), who … Read more
Representative image Bengaluru: Consumer stickiness, average order size increasing to $15-20 and the possibility of selling other healthcare services like online doctor consultation and diagnostics services have caught the interest of large strategic names like Reliance Industries and Amazon, driving them to the e-pharmacy sector. E-pharmacy had over 3 million users before the pandemic struck … Read more
Reliance Industries’ (RIL) shares, which have been leading the rally in benchmark indices recently, were downgraded by two prominent brokerages on Tuesday. Edelweiss downgraded the stock to ‘hold’ with a target price of Rs 2,105 while CLSA downgraded it to ‘buy’ from ‘outperform’ while raising the target price to Rs 2,250 to factor in high … Read more
Absence of new economy stocks a big hindrance for Asia markets outside of China, says Mark Matthews, Head of Research, Asia. I am literally pinching myself. Look at what we were reporting in the month of March versus what we are staring at right now. In March, it was panic and it was fear and … Read more